BVX20
BVX20 is a human monoclonal antibody that binds to CD20. BVX20 can kill B-cells through recruiting the immune system. BVX20 can be studied in research for relapsed or chemotherapy-resistant follicular B-cell NHL and CD20-positive diffuse large B-cell NHL[1].
Product Specifications
UNSPSC
12352203
Target
CD20
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Narayanan Suresh. Profiles of Indian biotech companies. Biotechnology Journal, 2009, 4 (3), pp.295.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6131314-01 0.1 mL
RNF220 (E3 Ubiquitin-protein Ligase RNF220, RING Finger Protein 220, C1orf164, FLJ10597) (AP)
Ask
View Details 
MBS6131314-02 5x 0.1 mL
RNF220 (E3 Ubiquitin-protein Ligase RNF220, RING Finger Protein 220, C1orf164, FLJ10597) (AP)
Ask
View Details 
MBS2138029-01 0.1 mL
PE Linked Monoclonal Antibody to Wingless Type MMTV Integration Site Family, Member 3A (WNT3A)
Ask
View Details